| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 8,997,926 | 5,892,067 |
| Prepaid expenses and other current assets | -48,586 | 15,693 |
| Due from sponsor | 5,254 | - |
| Long-term prepaid insurance | -61,667 | -61,667 |
| Accrued expenses | -20,342 | 13,216 |
| Interest earned on marketable securities held in trust account | 9,465,640 | 6,233,453 |
| Net cash used in operating activities | -383,057 | -282,196 |
| Advances from related party | 44,938 | 44,938 |
| Proceeds from sale of units, net of underwriting discounts paid | 0 | 0 |
| Proceeds from sale of private placements warrants | 0 | 0 |
| Proceeds from promissory note - related party | 0 | 0 |
| Repayment of promissory note - related party | 0 | 0 |
| Payment of offering costs | 0 | 0 |
| Net cash provided by financing activities | 44,938 | 44,938 |
| Investment of cash into trust account | 0 | 0 |
| Net cash used in investing activities | 0 | 0 |
| Net change in cash | -338,119 | -237,258 |
| Cash and cash equivalents at beginning of period | 483,572 | - |
| Cash and cash equivalents at end of period | 145,453 | - |
GP-Act III Acquisition Corp. (GPAT)
GP-Act III Acquisition Corp. (GPAT)